Bio-Techne Corporation stock research
FY2026 Q3
Bio-Techne (TECH) Gross Margin — Quarter Ended Mar 31, 2026
Revenue increased sequentially, leading to higher gross profit and an improved gross margin. Compared to the same quarter last year, revenue and gross profit were lower, and gross margin weakened slightly.
Gross margin takeaway
Quarter ended Mar 31, 2026 · FY2026 Q3
Revenue increased sequentially, leading to higher gross profit and an improved gross margin. Compared to the same quarter last year, revenue and gross profit were lower, and gross margin weakened slightly.
- The sequential improvement in gross margin was driven by a combination of higher revenue and lower cost of revenue. This offset the year-over-year decline in revenue and increase in cost of revenue.
- Compared to the prior quarter, gross margin improved as revenue grew and cost of revenue declined. Year-over-year, gross margin weakened due to lower revenue and higher cost of revenue.
Gross margin snapshot
The selected quarter's reported revenue, gross profit, direct costs, and margin comparisons.
Gross margin
66.9%
Gross profit
$208.3M
Revenue
$311.4M
Cost of revenue
$103.1M
Quarter-over-quarter change
+2.2 pts
Year-over-year change
-1.0 pts
Quarterly gross margin trend
A four-quarter view of the revenue and direct-cost bridge behind gross margin.
| Period | Revenue | Gross profit | Cost of revenue | Gross margin |
|---|---|---|---|---|
| Jun 30, 2025 | $317.0M | $198.8M | $118.2M | 62.7% |
| Sep 30, 2025 | $286.6M | $188.1M | $98.4M | 65.6% |
| Dec 31, 2025 | $295.9M | $191.3M | $104.6M | 64.6% |
| Mar 31, 2026 | $311.4M | $208.3M | $103.1M | 66.9% |
Quarterly comparisons
Compare the selected margin with the preceding quarter and the same fiscal quarter one year earlier.
Previous-quarter change
Dec 31, 2025
+2.2 pts
Year-over-year change
Mar 31, 2025
-1.0 pts
What the margin says
Filing-constrained interpretation of margin direction, comparisons, and what to monitor next.
The sequential improvement in gross margin was driven by a combination of higher revenue and lower cost of revenue. This offset the year-over-year decline in revenue and increase in cost of revenue.
Compared to the prior quarter, gross margin improved as revenue grew and cost of revenue declined. Year-over-year, gross margin weakened due to lower revenue and higher cost of revenue.
Monitor cost of revenue trends, as it increased year-over-year and was a key factor in the margin decline.
Peer context
Latest available gross margins for related public companies.
| Company | Gross margin |
|---|---|
| Bio-Techne Corporation (TECH) | 66.9% |